These are the factors that typically point toward the slower path: Prior intolerable nausea or vomiting on semaglutide, tirzepatide, or other GLP-1 medications History of GERD, gastroparesis, or functional GI disorders Lower body weight, where the effective dose-per-kilogram is relatively higher at standard doses First-time users of peptide or GLP-class medications with no tolerability baseline The slow-titration approach does not change the target dose or the expected outcomes
Further dose increases to 7.5 mg, 10 mg, 12.5 mg and 15 mg may be considered at intervals of at least 4 weeks, depending on individual response and tolerability
This is one of the biggest misconceptions around GLP-1 medications
But with the company's main source of growth set to be extinguished, its unclear how it can sustain its lofty valuation, with the stock trading at a price-to-earnings ratio of about 87x
Acc Chem Res 14:393400 Brand MD, Affourtit C, Esteves TC, Green K, Lambert AJ, Miwa S, Pakay JL, Parker N (2004) Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins
Always keep the medication in your carry-on luggage to avoid the extreme temperature changes and risks associated with checked bags